For research use only. Not for therapeutic Use.
SSAA09E2 is a novel inhibitor of SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
| Catalog Number | I036646 |
| CAS Number | 883944-52-3 |
| Synonyms | SSAA-09E2; SSAA 09E2; SSAA09E2 |
| Molecular Formula | C16H20N4O2 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | N-[[4-(4-Methyl-1-piperazinyl)phenyl]methyl]-5-isoxazolecarboxamide |
| InChI | InChI=1S/C16H20N4O2/c1-19-8-10-20(11-9-19)14-4-2-13(3-5-14)12-17-16(21)15-6-7-18-22-15/h2-7H,8-12H2,1H3,(H,17,21) |
| InChIKey | OMRXBNSVRJWWAZ-UHFFFAOYSA-N |
| SMILES | O=C(C1=CC=NO1)NCC2=CC=C(N3CCN(C)CC3)C=C2 |
| Reference | 1: Adedeji AO, Severson W, Jonsson C, Singh K, Weiss SR, Sarafianos SG. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol. 2013;87(14):8017-8028. doi:10.1128/JVI.00998-13 |
